Title:
WNT PATHWAY INHIBITOR COMPOUND
Document Type and Number:
WIPO Patent Application WO/2024/022365
Kind Code:
A1
Abstract:
The present invention relates to a Wnt pathway inhibitor compound represented by formula (I), a pharmaceutical composition comprising the compound, and use of the compound of formula (I) in preventing and/or treating cancers, tumors, inflammatory diseases, autoimmune diseases, or immune-mediated diseases.
Inventors:
CHEN YUFENG (CN)
WU PENG (CN)
CHEN KAIXUAN (CN)
JIN CHAOFAN (CN)
WANG YOUPING (CN)
CHEN KEKE (CN)
CHEN MENG (CN)
HE NANHAI (CN)
WU PENG (CN)
CHEN KAIXUAN (CN)
JIN CHAOFAN (CN)
WANG YOUPING (CN)
CHEN KEKE (CN)
CHEN MENG (CN)
HE NANHAI (CN)
Application Number:
PCT/CN2023/109227
Publication Date:
February 01, 2024
Filing Date:
July 26, 2023
Export Citation:
Assignee:
ADLAI NORTYE BIOPHARMA CO LTD (CN)
International Classes:
C07D471/04; A61K31/519; A61P35/00; C07D401/14; C07D403/14; C07D475/04
Domestic Patent References:
| WO2022089454A1 | 2022-05-05 | |||
| WO2023143501A1 | 2023-08-03 |
Foreign References:
| CN112218865A | 2021-01-12 | |||
| CN109310690A | 2019-02-05 | |||
| CN106458983A | 2017-02-22 | |||
| CN104379583A | 2015-02-25 |
Attorney, Agent or Firm:
FONDEE IP LAW LLC (CN)
Download PDF: